Refractory status epilepticus responding to lidocaine: a case report
Author(s) -
Gökhan Özer
Publication year - 2018
Publication title -
the european research journal
Language(s) - English
Resource type - Journals
ISSN - 2149-3189
DOI - 10.18621/eurj.361883
Subject(s) - status epilepticus , medicine , phenytoin , lidocaine , phenobarbital , anesthesia , concomitant , epilepsy , refractory (planetary science) , carbamazepine , anticonvulsant , surgery , physics , psychiatry , astrobiology
Status epilepticus is a life-threatening condition, which is associated with a high mortality and morbidity when left untreated. It is defined as a continuous seizure lasting more than 30 min or successive seizures with no recovery between any of them . Mortality of status epilepticus depends on the duration and type of seizure, concomitant diseases and age of the patient. Managament of status epilepticus includes ensuring adequate airway, stabilization of circulation and use of antiepileptic drugs. Benzodiazepines, phenobarbital, phenytoin, fosphenytoin, general anesthesia and lidocaine are used for the treatment of status epilepticus. Here, we discuss a patient with refractory status epilepticus who achieved a very good response and full recovery only with lidocain infusion among all forms of therapy given.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom